Baseline Parameters | 28-day outcome | P value | |
---|---|---|---|
Survival n = 61 | 28-day death n = 24 | ||
Gender | |||
 Male | 41 (67.2) | 14 (58.3) | 0.460 |
 Female | 20 (32.8) | 10 (41.7) |  |
Age, years | 65 (26) | 74 (18) | 0.013 |
APACHE II, score | 22 (7) | 34 (7) | < 0.001 |
SOFA, score | 4 (2) | 7 (3) | 0.636 |
BPGM, ng/ml | |||
 Negative | 45 (73.8) | 5 (20.8) | < 0.001 |
 Positive | 16 (26.2) | 19 (79.2) |  |
Lactate, mmol/l | 3.2 (2.1) | 3.6 (2.8) | 0.136 |
PCT, ng/ml | 20.8(55) | 43(81) | 0.064 |
LDH, IU/l | 328 (455) | 461 (555) | 0.133 |
AG, mmol/l | 17.6 (7.6) | 19.9 (10.1) | 0.488 |
CK, IU/l | 185 (403) | 149 (859) | 0.938 |
CK-MB, ng/ml | 24 (31) | 27 (32) | 0.522 |
NT-proBNP, pg/ml | 3456 (4059) | 4810 (7442) | 0.084 |
cTnI, ng/ml | 0.038(0.19) | 0.529 (1.92) | < 0.001 |
LVEF-S,% | 52 (6) | 36 (8) | < 0.001 |
Tei Index | 0.38 (0.15) | 0.65 (0.05) | < 0.001 |